The Joint Associations Committee (JAC) has raised some material concerns on behalf of its members in relation to the Packaged Retail and Insurance-based Investment Products (Priips) Key Information Document (Kid) regulation in terms of interpretation and implementation issues. In a letter to the European Commission (EC) and the European Supervisory Authorities (ESAs) the industry association points at a number of general issues around the applicability of the Priips regime to OTC derivatives as

Continue reading and get unlimited access for 7 days with a free trial of SRP.

Get a free trial

Already a subscriber? Login